Yılmaz Öztekin Gülsüm Meral, Genç Ahmet
Department of Cardiology University of Health Sciences, Antalya Training and Research Hospital, Antalya, Türkiye.
Turk Kardiyol Dern Ars. 2023 Mar;51(2):129-134. doi: 10.5543/tkda.2023.26900.
Cardiac biomarkers can help diagnose and predict heart failure prognosis. High-sensitivity troponin T has frequently been investigated in ischemic heart failure studies. However, the relation between high-sensitivity troponin T and mortality in nonischemic heart failure and its level indicating poor prognosis remain unclear. This study aimed to show whether high-sensitivity troponin T is a predictor of all-cause mortality and the cut-off value for high-sensitivity troponin T in patients with nonischemic heart failure with reduced ejection fraction.
We included 249 nonischemic heart failure patients with left ventricular ejection fraction ≤ 40%, age ≥ 18 years, and high-sensitivity troponin T level known.
Of the patients, 59.8% were male, 73.5% were New York Heart Association I or II, and the median age was 64. High-sensitivity troponin T value of the patients was 18 ng/L [inter-quartile range, 10-34]. The cut-off value of high-sensitivity troponin T for all-cause mortality was 21.5 ng/L, with 72.6% sensitivity and 69.9% specificity (area under the curve: 0.760, 95% CI: 0.692-0.828, P < 0.001). Patients were compared according to the 21.5 ng/L high-sensitivity troponin T cut-off value. At 30-month follow-up, all-cause mortality was 29.3%. According to the Kaplan-Meier analysis, the mortality rate was 14% in the high-sensitivity troponin T < 21.5 ng/L group, while the mortality rate was 50% in the high-sensitivity troponin T ≥ 21.5 ng/L group (P < 0.001, log-rank test). Baseline high-sensitivity troponin T was inde-pendently associated with all-cause mortality in nonischemic heart failure with reduced ejection fraction when adjusted for estimated glomerular filtration rate, hemoglobin, N-terminal pro-brain natriuretic peptide, body mass index, and left atrial diameter (hazard ratio: 1.012, 95% confidence interval: 1.003-1.020, P = 0.005).
The high-sensitivity troponin T cut-off value was 21.5 ng/L to predict a worse prognosis in nonischemic heart failure with reduced ejection fraction. There was an independent association between high-sensitivity troponin T and all-cause mortality.
心脏生物标志物有助于诊断和预测心力衰竭的预后。高敏肌钙蛋白T在缺血性心力衰竭研究中经常被研究。然而,高敏肌钙蛋白T与非缺血性心力衰竭死亡率之间的关系及其提示预后不良的水平仍不清楚。本研究旨在表明高敏肌钙蛋白T是否为全因死亡率的预测指标以及射血分数降低的非缺血性心力衰竭患者高敏肌钙蛋白T的临界值。
我们纳入了249例左心室射血分数≤40%、年龄≥18岁且已知高敏肌钙蛋白T水平的非缺血性心力衰竭患者。
患者中,59.8%为男性,73.5%为纽约心脏协会I级或II级,中位年龄为64岁。患者的高敏肌钙蛋白T值为18 ng/L[四分位间距,10 - 34]。高敏肌钙蛋白T预测全因死亡率的临界值为21.5 ng/L,敏感性为72.6%,特异性为69.9%(曲线下面积:0.760,95%CI:0.692 - 0.828,P < 0.001)。根据21.5 ng/L的高敏肌钙蛋白T临界值对患者进行比较。在30个月的随访中,全因死亡率为29.3%。根据Kaplan-Meier分析,高敏肌钙蛋白T < 21.5 ng/L组的死亡率为14%,而高敏肌钙蛋白T≥21.5 ng/L组的死亡率为50%(P < 0.001,对数秩检验)。在校正估计肾小球滤过率、血红蛋白、N末端脑钠肽前体、体重指数和左心房直径后,基线高敏肌钙蛋白T与射血分数降低的非缺血性心力衰竭的全因死亡率独立相关(风险比:1.012,95%置信区间:1.003 - 1.020,P = 0.005)。
高敏肌钙蛋白T的临界值为21.5 ng/L,以预测射血分数降低的非缺血性心力衰竭的更差预后。高敏肌钙蛋白T与全因死亡率之间存在独立关联。